Sensus Healthcare, Inc
SRTS Real Time Price USDRecent trades of SRTS by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by SRTS's directors and management
Government lobbying spending instances
-
$20,000 Oct 13, 2020 Issue: Health Issues Medicare/Medicaid
-
$60,000 Jul 20, 2020 Issue: Health Issues Medicare/Medicaid
-
$20,000 Jan 06, 2020 Issue: Medicare/Medicaid Health Issues
-
$60,000 Oct 18, 2019 Issue: Medicare/Medicaid Health Issues
-
$60,000 Jul 17, 2019 Issue: Health Issues Medicare/Medicaid
-
$60,000 Apr 18, 2019 Issue: Health Issues Medicare/Medicaid
-
$20,000 Oct 15, 2014 Issue: Medicare/Medicaid
-
$20,000 Jan 07, 2014 Issue: Health Issues Manufacturing Taxation/Internal Revenue Code Medicare/Medicaid Medical/Disease Research/Clinical Labs
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Radiotherapy mobile and wireless device workflow management system Feb. 06, 2024
-
Patent Title: Real-time x-ray dosimetry in intraoperative radiation therapy Jun. 29, 2021
-
Patent Title: Hybrid ultrasound-guided superficial radiotherapy system and method Jun. 08, 2021
-
Patent Title: Systems and methods for real time beam sculpting intra-operative-radiation-therapy treatment planning Mar. 09, 2021
-
Patent Title: Robotic intraoperative radiation therapy May. 12, 2020
-
Patent Title: Dermatology radiotherapy system with hybrid imager Mar. 24, 2020
-
Patent Title: Robotic iort x-ray radiation system with calibration well Jul. 16, 2019
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of SRTS in WallStreetBets Daily Discussion
Recent insights relating to SRTS
Recent picks made for SRTS stock on CNBC
ETFs with the largest estimated holdings in SRTS
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view SRTS Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.